Cargando…

Risk Factors and Drug Resistance of the MDR Acinetobacter Baumannii in Pneumonia Patients in ICU

OBJECTIVE: To investigate the risk factors and drug resistance of MDR Acinetobacter baumannii in pneumonia patients. METHODS: From January 2013 to February 2016, 98 pneumonia patients with MDR Acinetobacter baumannii in our hospital ICU were selected as the observation group, and 49 pneumonia patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Jichen, Li, Xiaomeng, Wang, Libo, Liu, Mingzhu, Zheng, Ke, Wang, Yanrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814959/ https://www.ncbi.nlm.nih.gov/pubmed/31667355 http://dx.doi.org/10.1515/med-2019-0090

Ejemplares similares

Community acquired multi drug resistant (MDR) Acinetobacter baumannii pneumonia in Malaysia – A case report
por: Mohd, Rozita, et al.
Publicado: (2018)

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii
por: Kumar, Sunil, et al.
Publicado: (2021)

Colistin Resistance in Acinetobacter baumannii MDR-ZJ06 Revealed by a Multiomics Approach
por: Hua, Xiaoting, et al.
Publicado: (2017)

Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections
por: Seleem, Noura M., et al.
Publicado: (2020)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

In vivo bactericidal effect of colistin–linezolid combination in a murine model of MDR and XDR Acinetobacter baumannii pneumonia
por: Ma, Xiao-Lin, et al.
Publicado: (2020)

Monitoring Multidrug-Resistant Acinetobacter Baumannii Infections in The Neurosurgery ICU Using a Real-Time Surveillance System
por: Zhu, Yuting, et al.
Publicado: (2022)

Sulbactam enhances the in vitro activity of sitafloxacin against extensively-drug resistant Acinetobacter baumannii
por: Xu, Nannan, et al.
Publicado: (2018)

Computationally Designed AMPs with Antibacterial and Antibiofilm Activity against MDR Acinetobacter baumannii
por: Alsaab, Fahad M., et al.
Publicado: (2023)

Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania
por: Kumburu, Happiness H, et al.
Publicado: (2019)

Infections from MDR strains (K. pneumoniae, P. aeruginosa, A. Baumannii complex) in a multivalent ICU
por: Kontopoulou, K, et al.
Publicado: (2014)

Identification of antibiotic resistance genes in the multidrug-resistant Acinetobacter baumannii strain, MDR-SHH02, using whole-genome sequencing
por: Wang, Hualiang, et al.
Publicado: (2017)

Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms
por: Zhang, Xiufeng, et al.
Publicado: (2021)

An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital
por: Ben-Chetrit, Eli, et al.
Publicado: (2018)

Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia
por: Inchai, Juthamas, et al.
Publicado: (2015)

Theoretical and Experimental Studies of Phosphonium Ionic Liquids as Potential Antibacterials of MDR Acinetobacter baumannii
por: Metelytsia, Larysa O., et al.
Publicado: (2022)

Differential Gene Expression of Efflux Pumps and Porins in Clinical Isolates of MDR Acinetobacter baumannii
por: AlQumaizi, Khalid I., et al.
Publicado: (2022)

Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in Vivo
por: Cha, Kyoungeun, et al.
Publicado: (2018)

Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran
por: Mirzaei, Bahman, et al.
Publicado: (2020)

Risk factors at icu admission for multi-resistant acinetobacter baumannii colonization and infection and its prediction capability
por: Vara Arlanzón, R, et al.
Publicado: (2015)

Acinetobacter baumannii Infection in Prior ICU Bed Occupants Is an Independent Risk Factor for Subsequent Cases of Ventilator-Associated Pneumonia
por: Tsakiridou, Eirini, et al.
Publicado: (2014)

Risk factors for pneumonia caused by antimicrobial drug-resistant or drug-sensitive Acinetobacter baumannii infections: A retrospective study
por: Wu, Feng, et al.
Publicado: (2020)

Resistance patterns of multidrug resistant Acinetobacter baumannii in an ICU of a tertiary care hospital, Malaysia
por: Janahiraman, Sivakami, et al.
Publicado: (2015)

Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU)
por: Alavi-Moghadam, Mostafa, et al.
Publicado: (2014)

Proteomic Analyses of Acinetobacter baumannii Clinical Isolates to Identify Drug Resistant Mechanism
por: Wang, Ping, et al.
Publicado: (2021)

Risk factors and clinical responses of pneumonia patients with colistin-resistant Acinetobacter baumannii-calcoaceticus
por: Aydemir, Hande, et al.
Publicado: (2019)

An ionophore breaks the multi-drug-resistance of Acinetobacter baumannii
por: De Oliveira, David M.P., et al.
Publicado: (2022)

Analysis on distribution features and drug resistance of clinically isolated Acinetobacter baumannii
por: Ren, Guangming, et al.
Publicado: (2016)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

715. Bulgecin A lowers Imipenem MICs in Clinical MDR Acinetobacter baumannii (ACB) Strains
por: Skalweit, Marion J, et al.
Publicado: (2019)

Corrigendum: Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in vivo
por: Cha, Kyoungeun, et al.
Publicado: (2022)

Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality
por: Li, Yu jun, et al.
Publicado: (2017)

Predictors of multidrug-resistant Acinetobacter baumannii infections: a retrospective analysis in surgical ICU patients
por: Camkiran, A, et al.
Publicado: (2012)

The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Evolution of Drug-resistant Acinetobacter baumannii After DCD Renal Transplantation
por: Jiang, Hong, et al.
Publicado: (2017)

Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR) Acinetobacter baumannii
por: Xiong, Yan Q., et al.
Publicado: (2019)

Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae
por: Carlson-Banning, Kimberly M., et al.
Publicado: (2013)

Clinical response and outcome of pneumonia due to multi-drug resistant Acinetobacter baumannii in critically ill patients
por: Shojaei, Lida, et al.
Publicado: (2016)

Immunosuppression broadens evolutionary pathways to drug resistance and treatment failure during Acinetobacter baumannii pneumonia in mice
por: Huo, Wenwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uneffrda1492jd59vo902g5rrm